BEUDAMED
    FDA Adverse Event Injury Summary report: N

    UNKNOWN EMPRINT ANTENNA

    MDR report key: 16096941 · Received January 4, 2023

    Report

    Report Number
    3004962788-2023-00001
    Event Type
    Injury
    Date Received
    January 4, 2023
    Date of Event
    November 1, 2022
    Report Date
    January 4, 2023
    Manufacturer
    COVIDIEN LP - SUPERDIMENSION INC
    Product Code
    LLZ
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    FR
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    UNKNOWN COOL TIP ELECRTRODE (LOT#UNKNOWN) UNKNOWN COOL TIP ELECRTRODE (LOT#UNKNOWN) UNKNOWN EMPRINT ANTENNA (LOT#UNKNOWN) TITLE: SINGLE-SESSION TRANSARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS THERMAL ABLATION IN LIVER METASTASES 3CM OR LARGER. SOURCE: DIAGNOSTIC AND INTERVENTIONAL IMAGING 103 (2022) 516-523. NOVEMBER 2022. MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

    Description of Event or Problem · 0

    ACCORDING TO THE LITERATURE SOURCE OF STUDY PERFORMED BETWEEN APRIL 2003 TO JANUARY 2021, A RETROSPECTIVE STUDY ANALYZED OUTCOMES OF 39 PATIENTS WITH LIVER METASTASIS 3 CM IN DIAMETER OR GREATER WHO UNDERWENT A TREATMENT THAT COMBINED TRANS ARTERIAL CHEMOEMBOLIZATION (TACE) WITH PERCUTANEOUS THERMAL ABLATION USING MICROWAVE ABLATION (MWA), OR CRYOABLATION. MWA WAS PERFORMED WITH EITHER THE EMPRINT SYSTEM OR COMPETITOR DEVICES. USING THE CTCAE COMPLICATION GRADING SCALE, THE AUTHORS REPORTED 4 GRADE 2 COMPLICATIONS INCLUDING PLEURAL EFFUSION REQUIRING DRAINAGE, SEGMENTAL PORTAL VEIN THROMBOSIS WITH SUBSEQUENT SEGMENTAL LIVER INFARCTION, AND A SUBCAPSULAR HEMATOMA. A TOTAL OF 103 PATIENTS UNDERWENT A TREATMENT THAT COMBINED TACE AND PERCUTANEOUS THERMAL ABLATION. THE AUTHORS DO NOT PROVIDE ANY ADDITIONAL DETAILS REGARDING THESE COMPLICATIONS OR INTERVENTIONS REQUIRED. THE ARTICLE DOES NOT SPECIFY WHICH DEVICE IS ASSOCIATED WITH THE REPORTED COMPLICATIONS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    909303 UNKNOWN EMPRINT ANTENNA System, image processing, radiological LLZ COVIDIEN LP - SUPERDIMENSION INC UNKNOWN EMPRINT ANTENNA

    Patients

    Seq Age Sex Outcome Treatment
    1 Female Required Intervention